Literature DB >> 28348172

Database-independent Protein Sequencing (DiPS) Enables Full-length de Novo Protein and Antibody Sequence Determination.

Alon Savidor1, Rotem Barzilay1, Dalia Elinger1, Yosef Yarden2, Moshit Lindzen2, Alexandra Gabashvili1, Ophir Adiv Tal1, Yishai Levin3.   

Abstract

Traditional "bottom-up" proteomic approaches use proteolytic digestion, LC-MS/MS, and database searching to elucidate peptide identities and their parent proteins. Protein sequences absent from the database cannot be identified, and even if present in the database, complete sequence coverage is rarely achieved even for the most abundant proteins in the sample. Thus, sequencing of unknown proteins such as antibodies or constituents of metaproteomes remains a challenging problem. To date, there is no available method for full-length protein sequencing, independent of a reference database, in high throughput. Here, we present Database-independent Protein Sequencing, a method for unambiguous, rapid, database-independent, full-length protein sequencing. The method is a novel combination of non-enzymatic, semi-random cleavage of the protein, LC-MS/MS analysis, peptide de novo sequencing, extraction of peptide tags, and their assembly into a consensus sequence using an algorithm named "Peptide Tag Assembler." As proof-of-concept, the method was applied to samples of three known proteins representing three size classes and to a previously un-sequenced, clinically relevant monoclonal antibody. Excluding leucine/isoleucine and glutamic acid/deamidated glutamine ambiguities, end-to-end full-length de novo sequencing was achieved with 99-100% accuracy for all benchmarking proteins and the antibody light chain. Accuracy of the sequenced antibody heavy chain, including the entire variable region, was also 100%, but there was a 23-residue gap in the constant region sequence.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28348172      PMCID: PMC5461544          DOI: 10.1074/mcp.O116.065417

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  23 in total

Review 1.  Proteomics by mass spectrometry: approaches, advances, and applications.

Authors:  John R Yates; Cristian I Ruse; Aleksey Nakorchevsky
Journal:  Annu Rev Biomed Eng       Date:  2009       Impact factor: 9.590

Review 2.  De novo sequencing of peptides by MS/MS.

Authors:  Joerg Seidler; Nico Zinn; Martin E Boehm; Wolf D Lehmann
Journal:  Proteomics       Date:  2010-02       Impact factor: 3.984

Review 3.  Hydrolysis and amino acid composition of proteins.

Authors:  M Fountoulakis; H W Lahm
Journal:  J Chromatogr A       Date:  1998-11-27       Impact factor: 4.759

Review 4.  Protein analysis by shotgun/bottom-up proteomics.

Authors:  Yaoyang Zhang; Bryan R Fonslow; Bing Shan; Moon-Chang Baek; John R Yates
Journal:  Chem Rev       Date:  2013-02-26       Impact factor: 60.622

5.  Hydrolysis of the peptide bond and amino acid modification with hydriodic acid.

Authors:  A S Inglis; P W Nicholls; C M Roxburgh
Journal:  Aust J Biol Sci       Date:  1971-12

6.  Reproducible microwave-assisted acid hydrolysis of proteins using a household microwave oven and its combination with LC-ESI MS/MS for mapping protein sequences and modifications.

Authors:  Nan Wang; Liang Li
Journal:  J Am Soc Mass Spectrom       Date:  2010-04-24       Impact factor: 3.109

7.  Sequencing-grade de novo analysis of MS/MS triplets (CID/HCD/ETD) from overlapping peptides.

Authors:  Adrian Guthals; Karl R Clauser; Ari M Frank; Nuno Bandeira
Journal:  J Proteome Res       Date:  2013-05-30       Impact factor: 4.466

8.  A recombinant decoy comprising EGFR and ErbB-4 inhibits tumor growth and metastasis.

Authors:  M Lindzen; S Carvalho; A Starr; N Ben-Chetrit; C-R Pradeep; W J Köstler; A Rabinkov; S Lavi; S S Bacus; Y Yarden
Journal:  Oncogene       Date:  2011-11-21       Impact factor: 9.867

9.  2016 update of the PRIDE database and its related tools.

Authors:  Juan Antonio Vizcaíno; Attila Csordas; Noemi del-Toro; José A Dianes; Johannes Griss; Ilias Lavidas; Gerhard Mayer; Yasset Perez-Riverol; Florian Reisinger; Tobias Ternent; Qing-Wei Xu; Rui Wang; Henning Hermjakob
Journal:  Nucleic Acids Res       Date:  2015-11-02       Impact factor: 16.971

10.  Complete De Novo Assembly of Monoclonal Antibody Sequences.

Authors:  Ngoc Hieu Tran; M Ziaur Rahman; Lin He; Lei Xin; Baozhen Shan; Ming Li
Journal:  Sci Rep       Date:  2016-08-26       Impact factor: 4.379

View more
  5 in total

1.  2018 YPIC Challenge: A Case Study in Characterizing an Unknown Protein Sample.

Authors:  Lindsay Pino; Andy Lin; Wout Bittremieux
Journal:  J Proteome Res       Date:  2019-10-07       Impact factor: 4.466

Review 2.  A perspective toward mass spectrometry-based de novo sequencing of endogenous antibodies.

Authors:  Sebastiaan C de Graaf; Max Hoek; Sem Tamara; Albert J R Heck
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 6.440

3.  Mass Spectrometry-Based De Novo Sequencing of Monoclonal Antibodies Using Multiple Proteases and a Dual Fragmentation Scheme.

Authors:  Weiwei Peng; Matti F Pronker; Joost Snijder
Journal:  J Proteome Res       Date:  2021-06-14       Impact factor: 4.466

Review 4.  Template-Based Assembly of Proteomic Short Reads For De Novo Antibody Sequencing and Repertoire Profiling.

Authors:  Douwe Schulte; Weiwei Peng; Joost Snijder
Journal:  Anal Chem       Date:  2022-07-14       Impact factor: 8.008

5.  ProAlanase is an Effective Alternative to Trypsin for Proteomics Applications and Disulfide Bond Mapping.

Authors:  Diana Samodova; Christopher M Hosfield; Christian N Cramer; Maria V Giuli; Enrico Cappellini; Giulia Franciosa; Michael M Rosenblatt; Christian D Kelstrup; Jesper V Olsen
Journal:  Mol Cell Proteomics       Date:  2020-10-05       Impact factor: 5.911

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.